Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

UTI treatment Companies

Urinary tract infections (UTIs) are common bacterial infections affecting the urinary system, and the treatment typically involves antibiotics. Several pharmaceutical companies produce medications used in the treatment of UTIs.

UTI treatment Key Companies

Latest UTI treatment Companies Update

Spero Therapeutics receives FDA approval for Tepezza (tebipenem HBr tablets): October 2023, Spero Therapeutics secured FDA approval for Tepezza, the first oral antibiotic specifically developed for the treatment of complicated urinary tract infections (cUTIs). This marks a significant breakthrough in addressing antibiotic resistance concerns.

AstraZeneca acquires Neobιοtics: August 2023, AstraZeneca acquired Neobιοtics, a developer of microbiome-based therapeutics, aiming to leverage Neobιοtics' expertise in urinary tract health for the development of novel non-antibiotic UTI treatments.

BD launches BD Vacutainer® Rapid ID Urine UTI Test System: June 2023, BD introduced its BD Vacutainer® Rapid ID Urine UTI Test System, a point-of-care diagnostic tool that rapidly identifies common urinary tract pathogens and antibiotic susceptibility, enabling faster and more informed treatment decisions.

List of UTI treatment Key Companies in the Market

Pfizer

Cipla Inc.

GlaxoSmithKline PLC

Shionogi & Co. Ltd

Novartis AG

AstraZeneca

Bayer AG

UTI treatment Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.